Successful treatment of steroid-refractory gastrointestinal acute graft-versus-host disease with adjuvant vedolizumab therapy in a pediatric allogeneic stem cell transplant recipient

被引：5
|
作者：
Pai, Vinita [1 ,2 ]
Abu-Arja, Rolla [3 ,4 ]
Auletta, Jeffery J. [3 ,4 ]
Rangarajan, Hemalatha G. [3 ,4 ]
机构：
[1] Ohio State Univ, Coll Pharm, 500 W 12Th Ave, Columbus, OH 43210 USA
[2] Nationwide Childrens Hosp, Pharm Dept, Columbus, OH USA
[3] Nationwide Childrens Hosp, Div Hematol Oncol Blood & Marrow Transplant, 700 Childrens Dr, Columbus, OH 43205 USA
[4] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA
来源：
PEDIATRIC BLOOD & CANCER | 2020年 / 67卷 / 08期
关键词：
D O I：
10.1002/pbc.28298
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Basiliximab is well Tolerated and Effective in the Treatment of Steroid-Refractory Acute Gut Graft-Versus-Host Disease After Pediatric Allogeneic Stem Cell Transplantation
    Ansari, F.
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S217 - S217
  • [22] Ruxolitinib for steroid-refractory acute graft-versus-host disease
    Toama, Wael
    Fiala, Mark
    Pusic, Iskra
    Westervelt, Peter
    Dipersio, John F.
    Schroeder, Mark
    TRANSPLANT INTERNATIONAL, 2020, 33 (02) : 244 - 246
  • [23] Lessons Learned from Early Experiences with Vedolizumab for Steroid-Refractory Acute Graft-versus-Host Disease with Gastrointestinal Involvement
    Bukauskas, Adomas
    Griskevicius, Laimonas
    Peceliunas, Valdas
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (09) : 1597 - 1597
  • [24] Pentostatin in steroid-refractory acute graft-versus-host disease
    Bolaños-Meade, J
    Jacobsohn, DA
    Margolis, J
    Ogden, A
    Wientjes, MG
    Byrd, JC
    Lucas, DM
    Anders, V
    Phelps, M
    Grever, MR
    Vogelsang, GB
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (12) : 2661 - 2668
  • [25] Basiliximab is well tolerated and effective in the treatment of steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation
    Massenkeil, G
    Rackwitz, S
    Genvresse, I
    Rosen, O
    Dörken, B
    Arnold, R
    BONE MARROW TRANSPLANTATION, 2002, 30 (12) : 899 - 903
  • [26] Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease Using Commercial Mesenchymal Stem Cell Products
    Murata, Makoto
    Teshima, Takanori
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [27] Basiliximab is well tolerated and effective in the treatment of steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation
    G Massenkeil
    S Rackwitz
    I Genvresse
    O Rosen
    B Dörken
    R Arnold
    Bone Marrow Transplantation, 2002, 30 : 899 - 903
  • [28] Treatment options in steroid-refractory acute graft-versus-host disease following hematopoietic stem cell transplantation
    Kim, Sara S.
    ANNALS OF PHARMACOTHERAPY, 2007, 41 (09) : 1436 - 1444
  • [29] Strategy on the Treatment of Steroid-Refractory Severe acute Graft-versus-Host Disease
    Yamin, T.
    Yi, L.
    Kaili, D.
    He, H.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S393 - S394
  • [30] Treatment of steroid-refractory acute graft-versus-host disease with ATG (Fresenius)
    Kamelander, J.
    Navratil, M.
    Koristek, Z.
    Doubek, M.
    Krejci, M.
    Brychtova, Y.
    Racil, Z.
    Mendelova, D.
    Weinreb, M.
    Mayer, J.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S241 - S241
12345